loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 2459078 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ANTIHEMOPHILIC FACTOR (RECOMBINANT), PEGYLATED (1)

filter

01 TAKEDA CANADA INC (1)

filter

01 KIT (1)

filter

01 2000UNIT/VIAL (1)

filter

01 Canada (1)

URL Supplier Web Content
KIT
2000UNIT/VIAL
ADYNOVATE
Canada
2459078
5ML
Schedule D
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 2459078

Looking for CTD TGA MCC DOSSIER APPLICATION 2459078 1

19

Takeda Pharmaceutical, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ANTIHEMOPHILIC FACTOR (RECOMBINANT), PEGYLATED, with a corresponding application number 2459078 and regulatory information .

proudly manufactured in the

Takeda Pharmaceutical's ADYNOVATE KIT, medication with 2000UNIT/VIAL of ANTIHEMOPHILIC FACTOR (RECOMBINANT), PEGYLATED.

Post Enquiry
POST ENQUIRY